Skip to main content

2022 PharmSci 360 Meeting Main banner

Tweets by 2022 PharmSci 360 Meeting

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Clinical Pharmacology - Biomolecular - Regulatory Guidance/Submissions

Clinical Pharmacology - Biomolecular - Regulatory Guidance/Submissions

Type here to filter the list

(M1130-11-65) A Retrospective Study of Mid-review Cycle Meetings (MRCMs) within Generic Drug User Fee Amendments (GDUFA) II

Favorite
(T1530-11-64) Quantifying the Disparate Impact of Eligibility Criteria on Recruiting Diverse Patients for a Clinical Trial in Non-Hodgkin’s Lymphoma

Favorite